Angioni, R.; Calì, B.; Vigneswara, V.; Crescenzi, M.; Merino, A.; Sánchez-RodrÃguez, R.; Liboni, C.; Hoogduijn, M.J.; Newsome, P.N.; Muraca, M.;
et al. Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice. Int. J. Mol. Sci. 2020, 21, 8874.
https://doi.org/10.3390/ijms21228874
AMA Style
Angioni R, Calì B, Vigneswara V, Crescenzi M, Merino A, Sánchez-RodrÃguez R, Liboni C, Hoogduijn MJ, Newsome PN, Muraca M,
et al. Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice. International Journal of Molecular Sciences. 2020; 21(22):8874.
https://doi.org/10.3390/ijms21228874
Chicago/Turabian Style
Angioni, Roberta, Bianca Calì, Vasanthy Vigneswara, Marika Crescenzi, Ana Merino, Ricardo Sánchez-RodrÃguez, Cristina Liboni, Martin J. Hoogduijn, Philip Noel Newsome, Maurizio Muraca,
and et al. 2020. "Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice" International Journal of Molecular Sciences 21, no. 22: 8874.
https://doi.org/10.3390/ijms21228874
APA Style
Angioni, R., Calì, B., Vigneswara, V., Crescenzi, M., Merino, A., Sánchez-RodrÃguez, R., Liboni, C., Hoogduijn, M. J., Newsome, P. N., Muraca, M., Russo, F. P., & Viola, A.
(2020). Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice. International Journal of Molecular Sciences, 21(22), 8874.
https://doi.org/10.3390/ijms21228874